Summary of thrombocytopenia events after SARS-CoV-2 vaccination. Individuals without a previously reported platelet disorders and suspected de novo ITP were identified in the Vaccine Adverse Events Reporting System. In patients with preexisting ITP, splenectomy and/or 5 more prior therapies led to a greater risk of exacerbation. Both groups of patients responded well to therapy.